Randomized Controlled Trial of Vitamin D Supplementation on Toll-like Receptor-2 (tlr-2) and Toll-like Receptor-4 (tlr-4) in Tuberculosis Spondylitis Patients
Overview
Authors
Affiliations
Background: Tuberculosis spondylitis accounts for approximately 50% of all cases of skeletal tuberculosis. Vitamin D plays a role in the immune system. Vitamin D helps in the activation of TLR-2 and TLR-4, which play a role in the process of tuberculosis infection. The objective of this study was to investigate the effect of oral supplementation with vitamin D on TLR-2 and TLR-4 levels in tuberculosis spondylitis patients.
Methods: The true Experiment Design Pretest-Posttest with Control Group (Pretest-Posttest with Control Group) was used for this research. TLR-2 and TLR-4 were measured by ELISA. Repeated ANOVA, ANOVA tests, and Kolmogorov-Smirnov normality tests on the SPSS program were used to statistically analyze the results.
Result: In the dose groups of 10,000 IU and 5000 IU, significant increases in the levels of vitamin D, TLR-2, and TLR-4 were observed at weeks 4 and 8 (p < 0.05). In the control group, there was no significant increase.
Conclusions: Vitamin D supplements can significantly increase TLR-2 and TLR-4 levels. Supplementation with vitamin D 10,000 IU/day for 8 weeks can increase vitamin D levels > 50 ng/dl to optimally act as an immunomodulator.
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications.
Cicchinelli S, Pignataro G, Gemma S, Piccioni A, Picozzi D, Ojetti V Int J Mol Sci. 2024; 25(2).
PMID: 38256033 PMC: 10815927. DOI: 10.3390/ijms25020962.